Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01205399 · ClinicalTrials.gov registry record
A Retrospective Study With Prospective Follow-Up of Complex Ventral Hernia Repair Utilizing the AlloMax Surgical Graft
A clinical trial, sponsored by C. R. Bard.
- Completed
- Registry status
- 78
- Enrollment target
NCT01205399 is a clinical trial that has completed, run by C. R. Bard. The registered enrollment target is 78 participants.
The verdict
NCT01205399 has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
This study will enroll subjects who underwent a ventral hernia repair using the AlloMax Surgical Graft at least 9 months in the past. All subjects who underwent a ventral hernia repair using the AlloMax Surgical Graft at least 9 months in the past will be contacted and asked to take part in this clinical study. The consented subjects' medical records will be reviewed for evidence of any risk factors of hernia recurrence, procedure time, complications and any documented recurrences. The subjects will be asked to undergo a physical exam to rule out any recurrences that were not documented in the medical records.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01205399
The ClinicalTrials.gov registry entry for NCT01205399 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01205399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01205399 about?
NCT01205399 is a clinical study titled "A Retrospective Study With Prospective Follow-Up of Complex Ventral Hernia Repair Utilizing the AlloMax Surgical Graft". This study will enroll subjects who underwent a ventral hernia repair using the AlloMax Surgical Graft at least 9 months in the past. All subjects who underwent a ventral hernia repair using the AlloMax Surgical Graft at least 9 months in the past will be contacted and asked to take part in this cl...
What is the current status of trial NCT01205399?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2010-09. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT01205399?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.